These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2903833)
21. [Psychophysiologic characteristics of the individual psychotropic activity of benzodiazepine derivatives under experimental conditions]. Val'dman AV; Kozlovskaia MM Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(6):911-9. PubMed ID: 27927 [TBL] [Abstract][Full Text] [Related]
22. [The neurochemical profile of the dorsal hippocampus and the antiaversive effects of anxiolytics in different models of anxiety in rats]. Talalaenko AN Zh Vyssh Nerv Deiat Im I P Pavlova; 1993; 43(3):621-6. PubMed ID: 8103252 [TBL] [Abstract][Full Text] [Related]
23. [Anxiolytic action of sodium valproate (possible role of gamma-aminobutyric acid in affective disorders)]. Raevskiĭ KS; Aleksandrovskiĭ IuA; Poiurovskiĭ MV; Kharlamov AN; Neznamov GG Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(4):574-9. PubMed ID: 2860764 [TBL] [Abstract][Full Text] [Related]
24. Antianxiety profile of ondansetron, a selective 5-HT3 antagonist, in a novel animal model. Roychoudhury M; Kulkarni SK Methods Find Exp Clin Pharmacol; 1997 Mar; 19(2):107-11. PubMed ID: 9151286 [TBL] [Abstract][Full Text] [Related]
25. GABAergic regulation of auditory sensory gating in low- and high-anxiety rats submitted to a fear conditioning procedure. Nobre MJ; Cabral A; Brandão ML Neuroscience; 2010 Dec; 171(4):1152-63. PubMed ID: 20937363 [TBL] [Abstract][Full Text] [Related]
26. The role of the hippocampus and 5-HT/GABA interaction in the central effects of benzodiazepine receptor ligands. Nazar M; Siemiatkowski M; Członkowska A; Sienkiewicz-Jarosz H; Płaźnik A J Neural Transm (Vienna); 1999; 106(5-6):369-81. PubMed ID: 10443544 [TBL] [Abstract][Full Text] [Related]
27. Anticonflict properties of the dipeptide Litoralon and of diazepam in rats. Schulz H; Feuer L Acta Physiol Hung; 1986; 67(3):331-8. PubMed ID: 2875599 [TBL] [Abstract][Full Text] [Related]
29. Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests. Jastrzębska-Więsek M; Siwek A; Partyka A; Kubacka M; Mogilski S; Wasik A; Kołaczkowski M; Wesołowska A Neuropharmacology; 2014 Oct; 85():253-62. PubMed ID: 24905144 [TBL] [Abstract][Full Text] [Related]
30. Dopamine D3 receptor knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepam. Leggio GM; Micale V; Le Foll B; Mazzola C; Nobrega JN; Drago F Eur Neuropsychopharmacol; 2011 Apr; 21(4):325-32. PubMed ID: 20627473 [TBL] [Abstract][Full Text] [Related]
31. [The comparative effect of melatonin and diazepam on shifts in the anxiety-phobia status of rats evoked by damage to the amygdala]. Arushanian EB; Chernysheva EM Eksp Klin Farmakol; 1997; 60(1):7-9. PubMed ID: 9162293 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of the anxiolytic-like profile of the GABAB receptor positive modulator CGP7930 in rodents. Jacobson LH; Cryan JF Neuropharmacology; 2008 Apr; 54(5):854-62. PubMed ID: 18328507 [TBL] [Abstract][Full Text] [Related]
33. Behavioural and radioligand analysis of the effect of two new piperazine derivatives with anxiolytic properties. Danchev N; Yaneva I; Popov P; Staneva-Stoycheva D Acta Physiol Pharmacol Bulg; 1987; 13(4):37-42. PubMed ID: 2896428 [TBL] [Abstract][Full Text] [Related]
34. [Monoamine, GABA, and glutamergic mechanisms of the anterior hypothalamus in anti-aversive effects of sedative and selective drugs in various models of anxiety]. Talalaenko AN; Gordienko DV; Markova OP; Goncharenko NV; Pankrat'ev DV Eksp Klin Farmakol; 2001; 64(2):20-4. PubMed ID: 11548441 [TBL] [Abstract][Full Text] [Related]
35. [The neurochemical profile of the septal nucleus accumbens in the anxiolytic action of tranquilizers on different models of anxiety]. Talalaenko AN; Panfilov VIu; Vozdigan SA; Pokramovich AI; Markova OP; Okhrimenko SV Eksp Klin Farmakol; 1997; 60(4):7-9. PubMed ID: 9376765 [TBL] [Abstract][Full Text] [Related]
36. Comparative assessment of the anxiolytic-like activities of honokiol and derivatives. Kuribara H; Kishi E; Kimura M; Weintraub ST; Maruyama Y Pharmacol Biochem Behav; 2000 Nov; 67(3):597-601. PubMed ID: 11164091 [TBL] [Abstract][Full Text] [Related]
37. [Nootropic and anxiolytic properties of endogenous ligands of benzodiazepine receptors and their structural analogs]. Akhundov RA; Voronina TA Biull Eksp Biol Med; 1984 Feb; 97(2):174-7. PubMed ID: 6141825 [TBL] [Abstract][Full Text] [Related]
39. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression. Wesołowska A; Nikiforuk A Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917 [TBL] [Abstract][Full Text] [Related]
40. Neurochemical characteristics of rats distinguished as benzodiazepine responders and non-responders in a new conflict test. Patel JB; Stengel J; Malick JB; Enna SJ Life Sci; 1984 Jun; 34(26):2647-53. PubMed ID: 6146084 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]